)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
Sprint Bioscience
Sprint Bioscience (SPRINT) investor relations material
Sprint Bioscience Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary11 Feb, 2026
Executive summary
Achieved a transformative year with strengthened financial position and strategic focus, highlighted by the sale of the TREX1 cancer program to Gilead Sciences for $14 million upfront and potential milestones up to $400 million.
Undertook portfolio reprioritization, including staff reductions and program discontinuations, to focus on high-potential projects and cost discipline.
Expanded scientific and commercial partnerships, with positive preclinical data and new collaborations in inflammation and oncology.
Financial highlights
Net revenue for the year was 167.2 MSEK, up from 65.6 MSEK year-over-year; Q4 revenue was 133.9 MSEK, up from 16.3 MSEK.
Operating income for the year reached 97.3 MSEK (previous year: -19.7 MSEK); Q4 operating income was 117.5 MSEK (previous year: -4.9 MSEK).
Net income for the year was 91.7 MSEK (previous year: -18.3 MSEK); Q4 net income was 113.2 MSEK (previous year: -4.2 MSEK).
Earnings per share for the year were 0.99/0.98 SEK (previous year: -0.26 SEK); Q4 EPS was 1.07/1.06 SEK (previous year: -0.06 SEK).
Cash flow from operations for the year was 83.5 MSEK (previous year: -23.4 MSEK); cash at year-end was 126.7 MSEK (previous year: 25.1 MSEK).
Outlook and guidance
Entering 2026 with a strong cash position, focused portfolio, and a clear agenda to drive licensing and partnerships for key programs.
No formal financial forecast provided.
VRK1 reacquisition: new partnering strategy
Impact of PETRA01 termination on portfolio
DCPS biomarker impact on partnering agenda
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Sprint Bioscience earnings date
Q1 202613 May, 2026
Sprint Bioscience
Next Sprint Bioscience earnings date
Q1 202613 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Sprint Bioscience AB is a Swedish biotechnology company focused on developing innovative cancer therapies. It specializes in drug discovery for oncology, leveraging a fragment-based drug discovery (FBDD) platform to accelerate the identification of promising molecules for cancer treatment. The company's research pipeline includes drug candidates targeting cancer metabolism and autophagy, with the aim of enhancing therapeutic approaches for hard-to-treat cancers. It is headquartered in Huddinge, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage